Another FAK inhibitor based on the same scaffold is TAE226, which has an IC50 of 5.5 nM and can exert significant anti-tumour activity in non-small cell lung cancer carrying EGFR mutations, including the T790M mutation [499]. Here, EGFR is linked to neoplasm.